Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Flanagan, Ellen M.
Jumbo Large Regular Text:
Print
Physicians

Ellen M. Flanagan, MD

Related Content

Services

  • Regional Anesthesiology

Share

Ellen M. Flanagan, MD

Department / Division
Anesthesiology / Anesthesiology-Regional Division

Address
DUMC 3094
Durham, NC 27710

Office Telephone
919-681-6754

Fax Telephone
919-681-8994

Training
  • MD, University of North Carolina–Chapel Hill School of Medicine, 1999

Residency
  • Internal Medicine, Moses Cone Health System (North Carolina), 1999-2000
  • Anesthesiology, Duke University Medical Center, 2000-2003

Clinical Interests
Perioperative ethics and care of the dying patient, palliative care, general anesthesiology, regional anesthesia

Research Interests
My research interests are in regional anesthesia using ultrasound technology and developing best practices. I am also interested in perioperative ethics and drug development for palliation of distressing symptoms at the end of life.
Summary of Research:
Dying patients are increasingly offered surgical, in addition to, medical treatment. Many of these patients have DNR orders. Respect of DNR orders is assumed in the hospitalized patient except when patients present for surgical procedures. Standards of care for management of the surgical patient with DNR orders do not exist on a national level, leading to haphazard care of patients, including automatic suspension of DNR orders. My research uses both qualitative and quantitative methods to assess what the dying patients’ expectation is for management of DNR orders in the perioperative period, specifically with regard to their decision making process and what constitutes desirable resuscitation. I am also researching the likelihood, duration and outcomes of intraoperative cardiac arrests and post-operative and prolonged ventilation. This information will enable us to more accurately communicate the risks and benefits of anesthesia and post-operative ventilation to our patients at the end of life. In doing so, we may increase our patient’s satisfaction, sense of autonomy and dignity should they require surgical intervention.

Finally, I am interested in the prospective study of medications that might alleviate symptoms of distress at the end of life, including delirium, agitation and pain using, while maintaining communication capacity allowing the dying patient to interact as peacefully with their loved ones as possible. Dexmedetomidine, a drug commonly used in the operating room and the intensive care unit.

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/ellen_m_flanagan